Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
What matters most is that the prescribing clinician has experience managing obesity as a chronic disease and can follow you over time
Recent studies have significantly enhanced our understanding of the role of GLP-1 beyond diabetes management, revealing its substantial involvement in pain modulation
Phase 2 clinical trials have demonstrated that GLP-3 can reduce body weight by up to 24.2% over a 48-week period, while also improving cardiometabolic parameters such as blood pressure, lipid profile, and insulin sensitivity
Best fit Maximum weight-loss potential Outcome signal Up to 22.5% mean loss Evidence cue SURMOUNT evidence Decision rhythm Week 1 / Weeks 4-8 / Months 3-6 Best-fit signals Choose Compounded Tirzepatide when these match your goal Maximum weight-loss potential Decision timeline What to expect as you compare Compounded Tirzepatide Timelines vary by goal, dose, baseline health, and consistency
